5/26/2015 12:00:00 AM
This alert addresses the ongoing patient safety incidents that occur when solutions intended for topical use are inadvertently injected. In most cases the cause of the error was due to the use of “open systems” where two solutions are poured into open containers such as gallipots; one of the solutions is intended for topical use while the other is for injectable use. The containers are not labelled and the solution is given by the wrong route. A common practice setting for these incidents has been where invasive or interventional procedures are carried out.
Three incidents are described. Two incidents involved severe harm from confusion between 2% chlorhexidine and x-ray contrast media in circumstances where both substances were in unlabelled gallipots (one during a lower limb angiogram and resulting in leg amputation, and one during a pacemaker insertion resulting in cardiac arrest and resuscitation). The third incident involved a patient undertaking renal dialysis with assistance from healthcare staff; the line was flushed with chlorhexidine from a gallipot instead of the intended saline solution and the patient became unwell but apparently recovered. A near miss also involved chlorhexidine and x-ray contrast medium, and occurred despite the skin preparation being on a separate trolley.
Recommended actions to mitigate the recurrence of such incidents are provided.
skin cleansing antiseptic solutions,
x-ray contrast media
Risk of death or severe harm due to inadvertent injection of skin preparation solution